Free Trial
NASDAQ:NATR

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

Nature's Sunshine Products logo
$24.55 -1.69 (-6.44%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$23.90 -0.65 (-2.64%)
As of 05/7/2026 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Advanced

Key Stats

Today's Range
$24.42
$26.19
50-Day Range
$23.00
$27.80
52-Week Range
$12.97
$28.14
Volume
79,012 shs
Average Volume
69,422 shs
Market Capitalization
$429.87 million
P/E Ratio
23.16
Dividend Yield
N/A
Price Target
$31.00
Consensus Rating
Buy

Company Overview

Nature's Sunshine Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

NATR MarketRank™: 

Nature's Sunshine Products scored higher than 87% of companies evaluated by MarketBeat, and ranked 86th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    Nature's Sunshine Products has a consensus price target of $31.00, representing about 26.3% upside from its current price of $24.55.

  • Amount of Analyst Coverage

    Nature's Sunshine Products has only been the subject of 3 research reports in the past 90 days.

  • Read more about Nature's Sunshine Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nature's Sunshine Products is 23.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.16.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nature's Sunshine Products is 23.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.70.

  • Price to Book Value per Share Ratio

    Nature's Sunshine Products has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nature's Sunshine Products' valuation and earnings.
  • Percentage of Shares Shorted

    1.32% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 2.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently decreased by 8.73%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Nature's Sunshine Products does not currently pay a dividend.

  • Dividend Growth

    Nature's Sunshine Products does not have a long track record of dividend growth.

  • News Sentiment

    Nature's Sunshine Products has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Nature's Sunshine Products this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    2 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nature's Sunshine Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $951,206.00 in company stock.

  • Percentage Held by Insiders

    3.10% of the stock of Nature's Sunshine Products is held by insiders.

  • Percentage Held by Institutions

    79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nature's Sunshine Products' insider trading history.
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NATR Stock News Headlines

Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.tc pixel
Nature's Sunshine Reports Strong First Quarter 2026 Results
See More Headlines

NATR Stock Analysis - Frequently Asked Questions

Nature's Sunshine Products' stock was trading at $21.58 at the beginning of the year. Since then, NATR shares have increased by 13.8% and is now trading at $24.55.

Nature's Sunshine Products, Inc. (NASDAQ:NATR) announced its quarterly earnings data on Thursday, May, 7th. The company reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.21 by $0.10. The firm had revenue of $122.89 million for the quarter, compared to analyst estimates of $122.15 million. Nature's Sunshine Products had a net margin of 4.07% and a trailing twelve-month return on equity of 14.36%.
Read the conference call transcript
.

Top institutional investors of Nature's Sunshine Products include Dimensional Fund Advisors LP (5.11%), Hillsdale Investment Management Inc. (1.81%), North Star Investment Management Corp. (0.57%) and Skylands Capital LLC (0.30%). Insiders that own company stock include Bryant J Yates, Daniel C Norman, Nathan G Brower, Jonathan David Lanoy and Fosun Pharmaceutical Shanghai.
View institutional ownership trends
.

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nature's Sunshine Products investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Meta Platforms (META) and Disc Medicine (IRON).

Company Calendar

Today
5/07/2026
Last Earnings
5/07/2026
Next Earnings (Estimated)
5/07/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Personal Products
Current Symbol
NASDAQ:NATR
CIK
275053
Employees
850
Year Founded
1972

Price Target and Rating

High Price Target
$33.00
Low Price Target
$29.00
Potential Upside/Downside
+26.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.06
Trailing P/E Ratio
23.16
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$19.52 million
Net Margins
4.07%
Pretax Margin
6.21%
Return on Equity
14.36%
Return on Assets
9.16%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.28
Quick Ratio
1.41

Sales & Book Value

Annual Sales
$480.14 million
Price / Sales
0.90
Cash Flow
$2.03 per share
Price / Cash Flow
12.07
Book Value
$9.23 per share
Price / Book
2.66

Miscellaneous

Outstanding Shares
17,510,000
Free Float
16,965,000
Market Cap
$429.87 million
Optionable
Optionable
Beta
0.95

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:NATR) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners